EUVIMEDDescobrir EUVIMED
FallberichtÜbersichtsarbeitOpen access

Treatment of Acute Hemolytic Transfusion Reaction due to ABO ‐Incompatible Red Blood Cell Transfusion: A Case Report, Review of the Literature and Recommendation

C Canté iD, P E Spronk iD, J Hulstein iD, K Le Poole, L Visser, F Swaneveld, H Vrielink iD

Journal of Clinical Apheresis · 2026

DOI: 10.1002/jca.70173 ↗

At a glance

Fallbericht in Journal of Clinical Apheresis, 2026. Written by C Canté and 6 co-authors. Institution: Department of Transfusion Medicine, Sanquin Blood Supply, Amsterdam, the Netherlands. Major MEDLINE topics: Erythrocyte Transfusion, ABO Blood-Group System, Blood Group Incompatibility, Transfusion Reaction. 17 references. The full text is freely available in PubMed Central.

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Although acute hemolytic transfusion reaction (AHTR) due to ABO‐incompatible red blood cell transfusion is a rare complication in high‐income countries, it is considered a medical emergency because of the severe intravascular hemolysis that can lead to major morbidity or death. AHTR can cause intravascular hemolysis, acute renal failure, disseminated intravascular coagulation (DIC), and shock, and therefore treatment should be prompted early and directed to prevent these complications. We present a case of AHTR due to ABO‐incompatible red blood cell transfusion successfully treated with high‐dose glucocorticoids, red blood cell, and therapeutic plasma exchange within 24 h. To our knowledge, there is no standard protocol for treatment of ABO‐incompatible red blood cell transfusions. We performed a review of the literature and made a recommendation for the treatment of AHTR due to ABO‐incompatible transfusion. Based on the existing literature and the presented case we advise, beside supportive measures and hemodialysis in case of renal failure, to consider more invasive therapies, such as therapeutic plasma exchange, red blood cell exchange or complement inhibiting drugs to prevent acute and long‐term complications. Daily measures of relevant laboratory parameters should be performed, and if hemolysis is apparent, repeated procedures should be considered.

Subjects

MeSH terms (MEDLINE)

Erythrocyte TransfusionABO Blood-Group SystemBlood Group IncompatibilityTransfusion ReactionHumansHemolysisPlasma ExchangeMaleFemale

Author keywords

ABO incompatibilityRBC transfusionacute hemolytic transfusion reaction

Substances

ABO Blood-Group System

Authors and institutions

  • Department of Transfusion Medicine, Sanquin Blood Supply, Amsterdam, the Netherlands.
  • Department of Intensive Care Medicine, Gelre Ziekenhuizen, Apeldoorn, the Netherlands.
  • Department of Clinical Chemistry, Gelre Ziekenhuizen, Apeldoorn, the Netherlands.

ORCID profiles: C Canté, P E Spronk, J Hulstein, H Vrielink

Cite

APA

Canté, C., Spronk, P. E., Hulstein, J., Le Poole, K., Visser, L., Swaneveld, F., & Vrielink, H. (2026). Treatment of Acute Hemolytic Transfusion Reaction due to ABO ‐Incompatible Red Blood Cell Transfusion: A Case Report, Review of the Literature and Recommendation. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70173

Vancouver

Canté C, Spronk PE, Hulstein J, Le Poole K, Visser L, Swaneveld F, et al. Treatment of Acute Hemolytic Transfusion Reaction due to ABO ‐Incompatible Red Blood Cell Transfusion: A Case Report, Review of the Literature and Recommendation. Journal of Clinical Apheresis. 2026. doi:10.1002/jca.70173

BibTeX
@article{Cant2026,
  author = {Canté, C and Spronk, P E and Hulstein, J and Le Poole, K and Visser, L and Swaneveld, F and Vrielink, H},
  title = {Treatment of Acute Hemolytic Transfusion Reaction due to ABO ‐Incompatible Red Blood Cell Transfusion: A Case Report, Review of the Literature and Recommendation},
  journal = {Journal of Clinical Apheresis},
  year = {2026},
  doi = {10.1002/jca.70173}
}
Start for free →